期刊文献+

肝细胞核因子4α在直肠癌中的临床意义及其与预后的关系 被引量:1

Clinical significance of hepatocyte nuclear factor 4αin rectal cancer and its relationship with prognosis
原文传递
导出
摘要 目的:探讨肝细胞核因子4α(HNF4α)在直肠癌中的临床意义及其与预后的关系。方法应用实时PCR法检测HNF4α在直肠癌中mRNA的表达水平,采用免疫组织化学法检测HNF4α蛋白表达水平,结合临床资料分析HNF4α与临床病理特征之间的关系,运用Kaplan-Meier法进行单因素生存分析,应用Cox回归模型进行多因素生存分析。结果在直肠癌组织中,HNF4α的mRNA(t=6.092, P<0.001)和蛋白(χ2=15.230,P<0.001)表达水平均低于癌旁组织,其蛋白表达与肿瘤临床分期(χ2=48.311,P<0.001)、浸润深度(χ2=23.911,P<0.001)、分化程度(χ2=20.787,P<0.001)、淋巴结转移(χ2=39.064,P<0.001)以及远处转移(χ2=5.146,P=0.04)相关,与性别和年龄无关。HNF4α低表达组患者术后3年生存率(43.8%)低于高表达组(95.5%),差异具有统计学意义(P<0.001)。单因素生存分析表明,患者的预后与HNF4α表达(χ2=28.778,P<0.001)、分化程度(χ2=26.680,P<0.001)、临床分期(χ2=32.702,P<0.001)、肿瘤浸润深度(χ2=6.226,P=0.013)、淋巴结转移(χ2=15.270,P<0.001)以及远处转移(χ2=21.817,P<0.001)相关,而与性别及年龄无关。多因素生存分析表明, HNF4α低表达(RR=6.084,P=0.028)是直肠癌患者预后评价的独立因素。结论 HNF4α参与直肠癌的发生、进展,是判断其预后的独立因子,可能成为直肠癌治疗的有效靶点。 Objective To investigate the clinical significance of hepatocyte nuclear factor 4α(HNF4α)in rectal cancer and its relationship with prognosis.Methods Real-time PCR was designed to detect the expression of HNF4αon mRNA level and the immunohistochemistry was used to determine the expression of HNF4αon protein level in rectal cancer tissue.The relationship between HNF4αexpression and clinical characteristics was also analysed.The Kaplan-Meier method was used for univariate analysis and a Cox proportional hazards regression model was performed for multivariate analysis.Results HNF4αwas low expressed both on mRNA (t=6.092,P<0.001)and protein level (χ2 =15.230,P<0.001)in rectal cancer tissue.HNF4αexpression on protein level was related with the clinical stage (χ2 =48.311,P<0.001),depth of invasion (χ2 =23.911,P<0.001),histological differentiation (χ2 =20.787,P<0.001),lymph node metastasis (χ2 =39.064,P<0.001)and distant metastasis (χ2 =5.146,P=0.04),while age and gender were not relevant.The cumulative 3-year overall survival of patients with low HNF4αexpression (43.8%)was much worse than the patients with high HNF4αexpression (95 .5%),and the difference was statistically sig-nificant (P<0.001).Univariate analysis revealed that HNF4αexpression (χ2 =28.778,P<0.001),differ-entiation (χ2 =26.680,P<0.001 ),clinical stage (χ2 =32.702,P<0.001 ),depth of invasion (χ2 =6.226,P=0.013),lymph node invasion (χ2 =15.270,P<0.001)and distant metastasis (χ2 =21.817, P<0.001)were statistically significant worse predictors for rectal cancer,whereas age and gender were not rel-evant.The multivariate Cox proportional hazard analysis revealed that HNF4αlow expression (RR=6.084, P=0.028)was independent prognostic markers for 3-year overall survival in the patients with rectal cancer. Conclusion HNF4αwas closely related to the tumorigenesis and progression of rectal cancer,which is an independent prognostic marker for rectal cancer,and which may be an effective target for the therapy of rectal cancer.
出处 《国际肿瘤学杂志》 CAS 2014年第9期704-708,共5页 Journal of International Oncology
关键词 直肠肿瘤 免疫组织化学 肝细胞核因子4Α Rectal neoplasms Immunohistochemistry Hepatocyte nuclear factor 4α
  • 相关文献

参考文献13

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics[J].CA Cancer J Clin.2011, 61(2):69-90.
  • 2王浩,陆培华,陶国青.结直肠癌肝转移机制的研究进展[J].国际肿瘤学杂志,2011,38(9):700-703. 被引量:2
  • 3刘海义(综述),梁小波(审校).早期直肠癌的治疗进展[J].国际肿瘤学杂志,2010,37(9):700-703. 被引量:4
  • 4Lazarevich NL, Shavochkina DA, Fleishman DI, et al. Deregulation of hepatocyte nuclear factor 4 (HNF4) as a marker of epithelial tumors progression[J]. Exp Oncol, 2010, 32(3): 167-171.
  • 5Oshima T, Kawasaki T, Ohashi R, et al. Downregulated P1 promoterdriven hepatocyte nuclear factor4alpha expression in human colorectal carcinoma is a new prognostic factor against liver metastasis[J].Pathol Int.2007, 57(2):82-90.
  • 6Darsigny M, Babeu JP, Dupuis AA, et al. Loss of hepatocyte nuclear factor 4alpha affects colonic ion transport and causes chronic inflammation resembling inflammatory bowel disease in mice[J]. PLoS One, 2009, 4(10): e7609.
  • 7Takano K, Hasegawa G, Jiang S, et al. Immunohistochemical staining for P1 and P2 promoter driven hepatocyte nuclear factor4alpha may complement mucin phenotype of differentiatedtype early gastric carcinoma[J].Pathol Int.2009, 59(7):462-470.
  • 8Yin C, Lin Y, Zhang X, et al. Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor4alpha gene[J].Hepatology.2008, 48(5):1528-1539.
  • 9张梁,元辉雄,黄永秩.结直肠癌组织中HNF4α的细胞内定位及临床意义[J].检验医学,2013,28(3):215-217. 被引量:4
  • 10Ehehalt F, Rümmele P, Kersting S, et al. Hepatocyte nuclear factor (HNF) 4α expression distinguishes ampullary cancer subtypes and prognosis after resection[J].Ann Surg.2011, 254(2):302-310.

二级参考文献50

  • 1龙云,唐红,刘聪,何芳,刘丽,赵连三,黄飞骏.肝细胞核因子4α和3β在人主要器官中的表达[J].世界华人消化杂志,2006,14(25):2504-2509. 被引量:11
  • 2Nash GM,Weiser MR,Guillem JG,et al.Long-term survival after transanal excision of T1 rectal cancer.Dis Colon Rectum,2009,52(4):577-582.
  • 3Nastro P,Beral D,Hartley J,et al.Local excision of rectal cancer:review of literature.Dig Surg,2005,22(1-2):6-15.
  • 4You YN,Baxter NN,Stewart A,et al.Is the increasing rate of local excision for stage 1rectal cancer in the United States justified? A nationwide cohort study from the National Cancer Database.Ann Surg,2007,245(5):726-733.
  • 5Folkesson J,Johansson R,P(a)hlman L,et al.Population-based study of local surgery for rectal cancer.Br J Surg,2007,94 (11):1421-1426.
  • 6Maclbouly KM,Remzi FH,Erkek BA,et al.Recurrence after transanal excision of T1 rectal cancer:should we be concerned? Dis Colon Rectum,2005,48(4):711-719.
  • 7Fang WL,Chang SC,Lin JK,et al.Metastatic potential in T1 and T2 colorectal cancer.Hepatogastroenterology,2005,52(66):1688-1691.
  • 8Rasheed S,Bowley DM,Aziz O,et al.Can depth of tumour invasion predict lymph node positivity in patients undergoing resection for early rectal cancer? A comparative study between T1 and T2 cancers.Colorectal Dis,2008,10(3):231-238.
  • 9Steele GD Jr,Herndon JE,Bleday R,et al.Sphincter-sparing treatment for distal rectal adenocarcinoma.Ann Surg Oncol,1999,6(5):433-441.
  • 10Endreseth BH,Myrvold HE,Romundstad P,et al.Transanal excision vs.major surgery for T1 rectal cancer.Dis Colon Rectum,2005,48(7):1380-1388.

共引文献7

同被引文献8

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部